Any feedback?
Literature summary for 3.2.1.117 extracted from
- Benefits of Prophylactic Short-Course Immune Tolerance Induction in Patients With Infantile Pompe Disease: Demonstration of Long-Term Safety and Efficacy in an Expanded Cohort. (2020), Front Immunol, 11, 1727.
Organism
| Organism | UniProt | Comment | Textmining |
|---|
Use of this online version of BRENDA is free under the CC BY 4.0 license. See terms of use for full details.
Release 2023.1 (January 2023)
Legal
Curated at
Member of
